Meridian Bioscience (VIVO) Tops Q2 EPS by 3c, Beat on Revenues; Reaffirms FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Meridian Bioscience (VIVO) Declares $0.125 Quarterly Dividend; 3.5% Yield
April 27, 2017 7:56 AM EDTMeridian Bioscience (NASDAQ: VIVO) declared a quarterly dividend of $0.125 per share, or $0.5 annualized.
The dividend will be payable on May 18, 2017, to stockholders of record on May 8, 2017, with an ex-dividend date of May 4, 2017.
The annual yield on the dividend is 3.5 percent.
For... More
